Global Alpha 1 Antitrypsin Deficiency Treatment Market Growth (Status and Outlook) 2025-2031

April 2025 | 109 pages | ID: GE5BCB62D3DFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global High Pressure Processing (HPP) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

High-Pressure Processing (HPP) is a cutting-edge USDA–approved all natural process that utilizes intense water pressure to protect against harmful bacteria without affecting a food product’s taste, texture, appearance or nutritional value. Products are packaged, sealed and then placed in a cylinder-shaped pressure chamber where it is surrounded by water. Up to 87,000 pounds of water pressure—roughly equal to five to six times the pressure found at the bottom of the deepest ocean—are exerted per square inch, protecting against harmful bacteria and sealing in freshness and flavor naturally, with no preservatives needed. HPP is one of the latest technologies that utilize non-heat methods to preserve food. It has been studied by scientists for more than a hundred years, but only within the past 20 years have companies started applying HPP commercially. In this report, we study the market size of food, which use high pressure processing. Some company, which offer High Pressure Processing (HPP) to the food manufacturing industry, is not covered in our report.

In the United States, key players of high pressure processing (HPP) include Hormel Food, Calavo Growers, Cargill, Wholly Guacamole, etc. Top five manufacturers hold a share over 35%. In terms of product, juices and beverages is the largest segment, with a share over 35%. And in terms of application, the largest application is supermarket, with a share over 60%.

LP Information, Inc. (LPI) ' newest research report, the “High Pressure Processing (HPP) Industry Forecast” looks at past sales and reviews total world High Pressure Processing (HPP) sales in 2024, providing a comprehensive analysis by region and market sector of projected High Pressure Processing (HPP) sales for 2025 through 2031. With High Pressure Processing (HPP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Pressure Processing (HPP) industry.

This Insight Report provides a comprehensive analysis of the global High Pressure Processing (HPP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High Pressure Processing (HPP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Pressure Processing (HPP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Pressure Processing (HPP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Pressure Processing (HPP).

This report presents a comprehensive overview, market shares, and growth opportunities of High Pressure Processing (HPP) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Meat and Poultry Products
• Juices and Beverages
• Fruit and Vegetable
• Seafood Products
• Others

Segmentation by Application:

• Supermarket
• Direct Store
• Online

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Hormel Food
• Calavo Growers
• Cargill
• Wholly Guacamole
• Good Foods
• Perdue Farms
• Suja Life
• Evolution Fresh
• Clearwater Seafoods
• Motivatit

Key Questions Addressed in this Report

What is the 10-year outlook for the global High Pressure Processing (HPP) market?

What factors are driving High Pressure Processing (HPP) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do High Pressure Processing (HPP) market opportunities vary by end market size?

How does High Pressure Processing (HPP) break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size (2020-2031)
  2.1.2 Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Alpha 1 Antitrypsin Deficiency Treatment by Country/Region (2020, 2024 & 2031)
2.2 Alpha 1 Antitrypsin Deficiency Treatment Segment by Indication
  2.2.1 Augmentation Therapy
  2.2.2 Cystic Fibrosis(CF)
  2.2.3 Non-CF Bronchiectasis(NCFB)
  2.2.4 Diabetes
  2.2.5 Other
2.3 Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication
  2.3.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Indication (2020 VS 2024 VS 2031)
  2.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
2.4 Alpha 1 Antitrypsin Deficiency Treatment Segment by End Users
  2.4.1 COPD
  2.4.2 Cystic Fibrosis(CF)
  2.4.3 Non-CF Bronchiectasis(NCFB)
  2.4.4 Diabetes
2.5 Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users
  2.5.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by End Users (2020 VS 2024 VS 2031)
  2.5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)

3 ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET SIZE BY PLAYER

3.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Player
  3.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Player (2020-2025)
  3.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY REGION

4.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (2020-2025)
4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth (2020-2025)
4.4 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth (2020-2025)
4.5 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (2020-2025)
5.2 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025)
5.3 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (2020-2025)
6.2 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025)
6.3 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (2020-2025)
7.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025)
7.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment by Region (2020-2025)
8.2 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025)
8.3 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST

10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Region (2026-2031)
  10.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.1.3 APAC Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.1.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.1.5 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Forecast
10.2 Americas Alpha 1 Antitrypsin Deficiency Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.2.2 Canada Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.2.3 Mexico Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.2.4 Brazil Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
10.3 APAC Alpha 1 Antitrypsin Deficiency Treatment Forecast by Region (2026-2031)
  10.3.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Forecast
  10.3.2 Japan Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.3.3 Korea Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.3.4 Southeast Asia Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.3.5 India Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.3.6 Australia Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
10.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.4.2 France Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.4.3 UK Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.4.4 Italy Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.4.5 Russia Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
10.5 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.5.2 South Africa Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.5.3 Israel Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
  10.5.4 Turkey Market Alpha 1 Antitrypsin Deficiency Treatment Forecast
10.6 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Indication (2026-2031)
10.7 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by End Users (2026-2031)
  10.7.1 GCC Countries Market Alpha 1 Antitrypsin Deficiency Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 GlaxoSmithKline
  11.2.1 GlaxoSmithKline Company Information
  11.2.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.2.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline Main Business Overview
  11.2.5 GlaxoSmithKline Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 Boehringer Ingelheim
  11.4.1 Boehringer Ingelheim Company Information
  11.4.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.4.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Boehringer Ingelheim Main Business Overview
  11.4.5 Boehringer Ingelheim Latest Developments
11.5 Teva Pharmaceutical Industries
  11.5.1 Teva Pharmaceutical Industries Company Information
  11.5.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Pharmaceutical Industries Main Business Overview
  11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Takeda
  11.6.1 Takeda Company Information
  11.6.2 Takeda Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.6.3 Takeda Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Takeda Main Business Overview
  11.6.5 Takeda Latest Developments
11.7 Baxter
  11.7.1 Baxter Company Information
  11.7.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.7.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Baxter Main Business Overview
  11.7.5 Baxter Latest Developments
11.8 Grifols
  11.8.1 Grifols Company Information
  11.8.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.8.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Grifols Main Business Overview
  11.8.5 Grifols Latest Developments
11.9 CSL Behring
  11.9.1 CSL Behring Company Information
  11.9.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 CSL Behring Main Business Overview
  11.9.5 CSL Behring Latest Developments
11.10 Kamada Ltd
  11.10.1 Kamada Ltd Company Information
  11.10.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.10.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Kamada Ltd Main Business Overview
  11.10.5 Kamada Ltd Latest Developments
11.11 Chiesi Pharmaceuticals
  11.11.1 Chiesi Pharmaceuticals Company Information
  11.11.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.11.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Chiesi Pharmaceuticals Main Business Overview
  11.11.5 Chiesi Pharmaceuticals Latest Developments
11.12 Kedrion Group
  11.12.1 Kedrion Group Company Information
  11.12.2 Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.12.3 Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Kedrion Group Main Business Overview
  11.12.5 Kedrion Group Latest Developments
11.13 Vertex Pharmaceuticals
  11.13.1 Vertex Pharmaceuticals Company Information
  11.13.2 Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.13.3 Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Vertex Pharmaceuticals Main Business Overview
  11.13.5 Vertex Pharmaceuticals Latest Developments
11.14 ProMetic Life Sciences
  11.14.1 ProMetic Life Sciences Company Information
  11.14.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product Offered
  11.14.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 ProMetic Life Sciences Main Business Overview
  11.14.5 ProMetic Life Sciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Alpha 1 Antitrypsin Deficiency Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Augmentation Therapy
Table 4. Major Players of CysticFibrosis(CF)
Table 5. Major Players of Non-CF Bronchiectasis(NCFB)
Table 6. Major Players of Diabetes
Table 7. Major Players of Other
Table 8. Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Indication (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025) & ($ millions)
Table 10. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
Table 11. Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by End Users (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025) & ($ millions)
Table 13. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)
Table 14. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Player (2020-2025)
Table 16. Alpha 1 Antitrypsin Deficiency Treatment Key Players Head office and Products Offered
Table 17. Alpha 1 Antitrypsin Deficiency Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Region (2020-2025)
Table 22. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Country (2020-2025)
Table 26. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025) & ($ millions)
Table 27. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
Table 28. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025) & ($ millions)
Table 29. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)
Table 30. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Region (2020-2025)
Table 32. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025) & ($ millions)
Table 33. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025) & ($ millions)
Table 34. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Country (2020-2025)
Table 36. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025) & ($ millions)
Table 37. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025) & ($ millions)
Table 38. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (2020-2025) & ($ millions)
Table 40. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Alpha 1 Antitrypsin Deficiency Treatment
Table 42. Key Market Challenges & Risks of Alpha 1 Antitrypsin Deficiency Treatment
Table 43. Key Industry Trends of Alpha 1 Antitrypsin Deficiency Treatment
Table 44. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by Indication (2026-2031) & ($ millions)
Table 47. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by End Users (2026-2031) & ($ millions)
Table 48. Pfizer Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 49. Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 50. Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Pfizer Main Business
Table 52. Pfizer Latest Developments
Table 53. GlaxoSmithKline Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 54. GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 55. GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. GlaxoSmithKline Main Business
Table 57. GlaxoSmithKline Latest Developments
Table 58. AstraZeneca Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 59. AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 60. AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. AstraZeneca Main Business
Table 62. AstraZeneca Latest Developments
Table 63. Boehringer Ingelheim Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 64. Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 65. Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Boehringer Ingelheim Main Business
Table 67. Boehringer Ingelheim Latest Developments
Table 68. Teva Pharmaceutical Industries Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 69. Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 70. Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Teva Pharmaceutical Industries Main Business
Table 72. Teva Pharmaceutical Industries Latest Developments
Table 73.Takeda Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 74.Takeda Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 75.Takeda Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76.Takeda Main Business
Table 77.Takeda Latest Developments
Table 78. Baxter Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 79. Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 80. Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Baxter Main Business
Table 82. Baxter Latest Developments
Table 83. Grifols Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 84. Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 85. Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. CSL Behring Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 89. CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 90. CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. CSL Behring Main Business
Table 92. CSL Behring Latest Developments
Table 93. Kamada Ltd Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 94. Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 95. Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Kamada Ltd Main Business
Table 97. Kamada Ltd Latest Developments
Table 98. Chiesi Pharmaceuticals Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 99. Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 100. Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Chiesi Pharmaceuticals Main Business
Table 102. Chiesi Pharmaceuticals Latest Developments
Table 103. Kedrion Group Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 104. Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 105. Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Kedrion Group Main Business
Table 107. Kedrion Group Latest Developments
Table 108. Vertex Pharmaceuticals Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 109. Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 110. Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Vertex Pharmaceuticals Main Business
Table 112. Vertex Pharmaceuticals Latest Developments
Table 113. ProMetic Life Sciences Details, Company Type, Alpha 1 Antitrypsin Deficiency Treatment Area Served and Its Competitors
Table 114. ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 115. ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. ProMetic Life Sciences Main Business
Table 117. ProMetic Life Sciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Alpha 1 Antitrypsin Deficiency Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Alpha 1 Antitrypsin Deficiency Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Country/Region (2024)
Figure 8. Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication in 2024
Figure 10. Alpha 1 Antitrypsin Deficiency Treatment in COPD
Figure 11. Global Alpha 1 Antitrypsin Deficiency Treatment Market: COPD (2020-2025) & ($ millions)
Figure 12. Alpha 1 Antitrypsin Deficiency Treatment in CysticFibrosis(CF)
Figure 13. Global Alpha 1 Antitrypsin Deficiency Treatment Market: CysticFibrosis(CF) (2020-2025) & ($ millions)
Figure 14. Alpha 1 Antitrypsin Deficiency Treatment in Non-CF Bronchiectasis(NCFB)
Figure 15. Global Alpha 1 Antitrypsin Deficiency Treatment Market: Non-CF Bronchiectasis(NCFB) (2020-2025) & ($ millions)
Figure 16. Alpha 1 Antitrypsin Deficiency Treatment in Diabetes
Figure 17. Global Alpha 1 Antitrypsin Deficiency Treatment Market: Diabetes (2020-2025) & ($ millions)
Figure 18. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users in 2024
Figure 19. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Player in 2024
Figure 20. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Region (2020-2025)
Figure 21. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size 2020-2025 ($ millions)
Figure 22. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size 2020-2025 ($ millions)
Figure 23. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2020-2025 ($ millions)
Figure 25. Americas Alpha 1 Antitrypsin Deficiency Treatment Value Market Share by Country in 2024
Figure 26. United States Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Region in 2024
Figure 31. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
Figure 32. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)
Figure 33. China Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. India Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Country in 2024
Figure 40. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
Figure 41. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)
Figure 42. Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. France Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Indication (2020-2025)
Figure 49. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by End Users (2020-2025)
Figure 50. Egypt Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 56. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 57. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 59. United States Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 60. Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 61. Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 62. Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 63. China Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 64. Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 65. Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 67. India Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 68. Australia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 69. Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 70. France Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 71. UK Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 72. Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 73. Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 74. Egypt Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 75. South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 76. Israel Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 77. Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)
Figure 78. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Indication (2026-2031)
Figure 79. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by End Users (2026-2031)
Figure 80. GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size 2026-2031 ($ millions)